Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Energy & Oil

A Major Contract Fails to Lift Nel ASA’s Stock

Robert Sasse by Robert Sasse
November 10, 2025
in Energy & Oil, European Markets, Hydrogen, Renewable Energy, Turnaround
0
Nel ASA Stock
0
SHARES
152
VIEWS
Share on FacebookShare on Twitter

Norwegian hydrogen technology firm Nel ASA has secured one of the largest orders in its corporate history, a development that signals a potential turnaround for the company. Despite the announcement of a contract exceeding $50 million, the market’s initial response was surprisingly negative, with shares declining significantly.

Details of the Landmark Agreement

On November 5th, Nel’s US subsidiary, Nel Hydrogen US, received orders valued at over $50 million. These orders were placed for the Norwegian hydrogen initiatives, HyFuel and Kaupanes. This contract stands as the second-largest overall order for Nel and, more notably, the single largest purchase order for their Proton Exchange Membrane (PEM) technology.

The agreement involves the supply of systems for two separate 20-megawatt projects, creating a combined capacity of 40 MW. The technology at the heart of these projects will be Nel’s containerized MC 500 PEM systems.

Key Contract Details:
* Total Value: Over $50 million USD
* Significance: Largest PEM order and second-largest overall order for Nel
* Delivery Timeline: Second half of 2026 through 2027
* Planned Commissioning: Early 2028

Market Reaction Contrasts with Corporate News

In a paradoxical move, investors sold off Nel shares following the positive news. On November 7th, the stock declined by 5.49 percent, closing at 2.48 Norwegian kroner. This price level keeps the equity in the lower half of its 52-week range, which spans from 1.95 kroner to 3.68 kroner.

Should investors sell immediately? Or is it worth buying Nel ASA?

This cautious sentiment is underpinned by the company’s recent financial performance. Nel reported a loss per share of 0.26 kroner and a negative profit margin of -43.75%. Revenue for the trailing twelve months was recorded at 1.05 billion kroner.

Strategic Importance and Government Backing

The HyFuel and Kaupanes projects are not just significant for Nel; they are also major initiatives within Norway’s national hydrogen strategy. Both have secured substantial state funding from Enova, with HyFuel receiving 180 million kroner and Kaupanes obtaining 206 million kroner in support. The plants will be constructed in the municipalities of Florø and Eigersund, key locations in the country’s expanding hydrogen infrastructure.

Hydrogen Solutions AS (HYDS) selected Nel as the primary equipment supplier, a decision based on the company’s established PEM technology. This endorsement could serve as a powerful reference, potentially leading to further large-scale orders.

Analyst Sentiment and Future Outlook

Market experts remain measured in their assessment of Nel’s prospects. An average rating of 3.82 from 17 analysts points to a neutral stance. The consensus price target of 2.22 kroner sits below the current trading price, reflecting ongoing concerns about the company’s sluggish revenue growth.

However, this multi-million dollar contract could mark a pivotal moment. The equipment will be manufactured at Nel’s automated production facility in Wallingford, USA, showcasing the company’s international manufacturing capabilities and its readiness to fulfill major international projects.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from February 7 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Camping World Stock
Consumer & Luxury

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Tellurian Stock
Energy & Oil

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026
Next Post
TSMC Stock

Semiconductor Giant TSMC Set to Implement Major Price Hikes

Solana Stock

Solana's Resurgence: Analyzing the Bullish Signals and Potential Pitfalls

AMD Stock

AMD Secures Key Intel Executive Amid Market Volatility

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com